Glucosamine, a popular joint supplement, linked to faster Alzheimer's progression

A large health-record analysis found that glucosamine use was associated with a 25% higher likelihood of mild cognitive impairment progressing to dementia. Lab experiments suggest the supplement may intensify an abnormal sugar-tagging process in the Alzheimer's brain, though clinical trials are needed to confirm if it causes harm. The study was published in Nature Metabolism.